Financials Shanghai INT Medical Instruments Co., Ltd.

Equities

1501

CNE100003NH7

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 09:08:20 26/04/2024 BST 5-day change 1st Jan Change
27.4 HKD -0.90% Intraday chart for Shanghai INT Medical Instruments Co., Ltd. -0.90% -4.20%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,606 5,714 3,111 4,266 4,445 4,441 - -
Enterprise Value (EV) 1 4,606 5,714 3,111 4,266 4,445 4,441 4,441 4,441
P/E ratio 35.1 x 47.2 x 21.8 x 32.6 x 28.3 x 21.9 x 16.7 x 13.1 x
Yield - - - - - - - -
Capitalization / Revenue 16.1 x 15.9 x - 7.28 x 5.9 x 4.54 x 3.46 x 2.67 x
EV / Revenue 16.1 x 15.9 x - 7.28 x 5.9 x 4.54 x 3.46 x 2.67 x
EV / EBITDA - 42,534,660 x - - - - - -
EV / FCF - - - -68 x - 96.6 x 27.8 x 20.1 x
FCF Yield - - - -1.47% - 1.04% 3.6% 4.98%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 166,000 166,000 166,000 168,000 170,998 175,107 - -
Reference price 2 27.75 34.42 18.74 25.39 25.99 25.36 25.36 25.36
Announcement Date 19/03/20 19/03/21 18/03/22 20/03/23 18/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 286.5 358.4 - 585.9 752.8 979 1,282 1,664
EBITDA - 134.3 - - - - - -
EBIT 1 - 112.4 - 145.3 178.3 208 272 347
Operating Margin - 31.35% - 24.8% 23.69% 21.25% 21.22% 20.85%
Earnings before Tax (EBT) 1 - 137.1 - 144.5 175.1 206 270 345
Net income 1 - 121.4 143 131.7 153.2 199 260 331
Net margin - 33.86% - 22.48% 20.35% 20.33% 20.28% 19.89%
EPS 2 0.7900 0.7300 0.8600 0.7800 0.9200 1.160 1.520 1.940
Free Cash Flow 1 - - - -62.75 - 46 160 221
FCF margin - - - -10.71% - 4.7% 12.48% 13.28%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - 23.12% 61.54% 66.77%
Dividend per Share - - - - - - - -
Announcement Date 19/03/20 19/03/21 18/03/22 20/03/23 18/03/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - -62.7 - 46 160 221
ROE (net income / shareholders' equity) - - - - - 11.4% 13.7% 15.8%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - 243 - 150 100 100
Capex / Sales - - - 41.51% - 15.32% 7.8% 6.01%
Announcement Date 19/03/20 19/03/21 18/03/22 20/03/23 18/03/24 - - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
25.36 CNY
Average target price
32.25 CNY
Spread / Average Target
+27.14%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1501 Stock
  4. Financials Shanghai INT Medical Instruments Co., Ltd.